100% found this document useful (1 vote)
217 views31 pages

Understanding Pulmonary Edema Causes

Pulmonary edema is a condition characterized by fluid accumulation in the lungs caused by fluid leaking from blood vessels into the lung tissue and air spaces. It can be caused by an imbalance of hydrostatic and oncotic pressures in the lungs due to conditions like heart failure or kidney disease. Symptoms include shortness of breath, cough, and chest pain. Diagnosis involves chest x-rays, blood tests, and echocardiography. Treatment focuses on reducing fluid buildup through oxygen, diuretics, and treating any underlying conditions.

Uploaded by

Mourian Aman
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
100% found this document useful (1 vote)
217 views31 pages

Understanding Pulmonary Edema Causes

Pulmonary edema is a condition characterized by fluid accumulation in the lungs caused by fluid leaking from blood vessels into the lung tissue and air spaces. It can be caused by an imbalance of hydrostatic and oncotic pressures in the lungs due to conditions like heart failure or kidney disease. Symptoms include shortness of breath, cough, and chest pain. Diagnosis involves chest x-rays, blood tests, and echocardiography. Treatment focuses on reducing fluid buildup through oxygen, diuretics, and treating any underlying conditions.

Uploaded by

Mourian Aman
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

PULMONARY EDEMA

A CONDITION CHARACTERIZED BY

FLUID ACCUMULATION IN THE LUNGS

CAUSED BY EXTRAVASATION OF FLUID

FROM PULMONARY VASCULATURE

INTO THE INTERSTITIUM AND ALVEOLI

OF THE LUNGS
REGULATING FORCES
HYDROSTATIC PRESSURE

-FAVORS MOVEMENT OF FLUID FROM THE


CAPILLARY INTO THE INTERSTITIUM

 ONCOTIC PRESSURE

-FAVORS MOVEMENT OF FLUID INTO THE VESSEL

MAINTENANCE

-LYMPHATIC IN THE TISSUE CARRY AWAY THE SMALL


AMOUNTS OF PROTEIN THAT MAY LEAK OUT

-TIGHT JUNCTION OF ENDOTHELIUM ARE


IMPERMEABLE TO PROTEIN
PATHOPHYSIOLOGY
 IMBALANCE OF STARLING FORCE
-INCREASE PULMONARY CAPILLARY
PRESSURE
-DECREASE PLASMA ONCOTIC
PRESSURE
-INCREASE NEGATIVE INTERSTITIAL
PRESSURE
 DAMAGE TO ALVEOLAR- CAPILLARY BARRIER
LYMPHATIC OBSTRUCTION
ETIOLOGY
IMBALANCE OF STARLING FORCE

A. RAISED PULMONARY CAPILLARY PRESSURE

-LEFT VENTRICULAR FAILURE

-VOLUME OVERLOAD

B. DECREASED PLASMA ONCOTIC PRESSURE

- HYPOALBUMINEMIA

C. HIGH NEGATIVE INTERSTITIAL PRESSURE

-RAPID REMOVAL OF PNEUMOTHORAX


ALTERED ALVEOLAR-CAPILLARY
MEMBRANE PERMEABILITY

o INHALED TOXINS

o CIRCULATING FOREIGN SUBSTANCES

o ASPIRATION

o ENDOGENOUS VASOACTIVE SUBSTANCES

o DISSEMINATED INTRAVASCULAR COAGULATION

o IMMUNOLOGIC—HYPERSENSITIVITY
PNEUMONITIS, DRUGS
LYMPHATIC INSUFFICIENCY
-AFTER LUNG TRANSPLANT

- LYMPHANGITIC CARCINOMATOSIS

-FIBROSING LYMPHANGITIS
UNKNOWN OR INCOMPLETELY
UNDERSTOOD
- HIGH-ALTITUDE PULMONARY EDEMA

- NEUROGENIC PULMONARY EDEMA

- NARCOTIC OVERDOSE

- PULMONARY EMBOLISM
CLASSIFICATION

o CARDIOGENIC PULMONARY EDEMA

o NON-CARDIOGENIC PULMONARY EDEMA

o NEUROGENIC PULMONARY EDEMA

o REEXPANSION PULMONARY EDEMA

o HIGH ALTITUDE PULMONARY EDEMA


CAUSES OF CARDIOGENIC PE

0 LV FAILURE

0 DYSRHYTHMIA

0 LV HYPERTROPHY AND CARDIOMYOPATHY

0 LV VOLUME OVER LOAD


NON CARDIOGENIC PE
0 INCREASED ALVEOLAR–CAPILLARY

MEMBRANE PERMEABILITY

0 DECREASED PLASMA ONCOTIC PRESSURE

0 DESTRUCTION OF SURFACTANT

0 LYMPHATIC INSUFFICIENCY OR OBSTRUCTION


NEUROGENIC PULMONARY EDEMA

PATIENTS WITH CENTRAL NERVOUS

SYSTEM DISORDERS AND WITHOUT

APPARENT PREEXISTING LV DYSFUNCTION


RE-EXPANSION PULMONARY EDEMA

DEVELOPS AFTER REMOVAL OF AIR OR

FLUID THAT HAS BEEN IN PLEURAL SPACE

FOR SOME TIME, POST- THORACENTESIS


HIGH ALTITUDE PULMONARY EDEMA

OCCURS IN YOUNG PEOPLE WHO HAVE

QUICKLY ASCENDED TO ALTITUDES ABOVE

2700M AND THEN PERFORM RIGOROUS

EXERCISE
STAGING OF PE
MILD: ONLY ENGORGEMENT OF PULMONARY

VASCULATURE IS SEEN.

MODERATE: THERE IS EXTRAVASATION OF FLUID

INTO THE INTERSTITIAL SPACE DUE TO CHANGES

IN ONCOTIC PRESSURE.

SEVERE: ALVEOLAR FILLING OCCURS.


CLINICAL MANIFESTATION
0 ACUTE (SUDDEN)

0 CHRONIC (LONG-TERM)
ACUTE SYMPTOMS

0 SHORTNESS OF BREATH

0 A FEELING OF SUFFOCATION

0 ANXIETY ,RESTLESSNESS

0 COUGH WITH FROTHY SPUTUM

0 EXCESSIVE SWEATING

0 PALE SKIN

0 CHEST PAIN

0 PALPITATION
LONG TERM(CHRONIC)

0 PARAXOSOMAL NOCTURNAL DYSPNEA

0 ORTHOPNEA

0 RAPID WEIGHT GAIN

0 LOSS OF APPETITE

0 FATIGUE

0 ANKLE AND LEG SWELLING


DIAGNOSIS
LABORATORY INVESTIGATIONS

ROUTINE; CBC

ARTERIAL BLOOD GAS ANALYSIS

SERUM CARDIAC BIOMARKERS


IMAGING
 CHEST RADIOGRAPHY

 ULTRASOUND

 ECHOCARDIOGRAPHY
• PULMONARY ARTERY CATHETERIZATION

PULMONARY CAPILLARY WEDGE

PRESSURE < 18 MMHG IS CONSISTENT WITH A

NON-CARDIOGENIC CAUSE.

PULMONARY CAPILLARY WEDGE

PRESSURE >20 MMHG FAVORS A

CARDIOGENIC CAUSE.
TREATMENT
EMERGENCY MANAGEMENT

-OXYGEN THERAPY

-POSITIVE PRESSURE VENTILATION

0 REDUCTION OF PRE LOAD

-LOOP DIURETICS

-NITRATE

- MORPHINE
REDUCTION OF AFTER LOAD AND
INOTROPIC SUPPORT

CONDITION THAT COMPLICATE PE MUST BE


CORRECTED

-INFECTION

-ACIDEMIA

-RENAL FAILURE

-ANEMIA

You might also like